Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	212	139	271	132	106	36
Market Cap Growth	-5.33%	-48.69%	104.97%	24.94%	195.56%	-19.92%
Enterprise Value	130	65	165	54	43	28
PE Ratio	-	-2.85	-8.22	-5.34	-4.77	-1.64
PS Ratio	2614.33	1719.26	263.49	115.74	-	-
PB Ratio	4.83	3.83	4.08	1.80	1.73	6.35
P/FCF Ratio	-5.79	-2.93	32.79	-6.31	-4.85	-1.67
P/OCF Ratio	-5.81	-2.94	31.40	-6.35	-4.90	-1.67
EV/Sales Ratio	1601.06	798.72	159.88	47.63	-	-
EV/EBITDA Ratio	-3.25	-1.35	-5.10	-2.25	-1.96	-1.28
EV/EBIT Ratio	-3.19	-1.33	-4.99	-2.20	-1.92	-1.26
EV/FCF Ratio	-3.73	-1.36	19.89	-2.60	-1.95	-1.28
Debt / Equity Ratio	0.05	0.06	0.04	0.00	0.01	0.25
Debt / EBITDA Ratio	-0.04	-0.04	-0.08	-0.01	-0.03	-0.07
Debt / FCF Ratio	-0.05	-0.04	0.31	-0.01	-0.03	-0.07
Quick Ratio	10.42	9.03	10.28	11.44	13.43	1.81
Current Ratio	10.59	9.21	10.44	11.66	13.62	1.89
Asset Turnover	0.00	0.00	0.01	0.01	0	0
Return on Equity (ROE)	-105.00%	-102.60%	-46.40%	-32.50%	-55.40%	-239.20%
Return on Assets (ROA)	-51.90%	-52.60%	-30.90%	-30.50%	-49.00%	-141.20%
Return on Capital (ROIC)	-108.93%	-134.89%	-49.38%	-33.80%	-36.08%	-312.10%
Earnings Yield	-21.94%	-35.06%	-12.17%	-18.71%	-20.96%	-61.08%
FCF Yield	-18.76%	-34.10%	3.05%	-15.86%	-20.64%	-60.04%
Buyback Yield / Dilution	-8.52%	-10.20%	-17.37%	-69.51%	-143.87%	-40.77%
Total Shareholder Return	-8.52%	-10.20%	-17.37%	-69.51%	-143.87%	-40.77%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).